Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmo Diet and Cancer Cohort

被引:16
作者
Elebro, Karin [1 ,2 ]
Butt, Salma [3 ]
Dorkhan, Mozhgan [4 ]
Jernstrom, Helena [1 ]
Borgquist, Signe [1 ,5 ]
机构
[1] Lund Univ, Div Oncol & Pathol, Skane Univ Hosp, S-22185 Lund, Sweden
[2] Skane Univ Hosp, Dept Plast & Reconstruct Surg, Malmo, Sweden
[3] Lund Univ, Dept Surg, Skane Univ Hosp, Malmo, Sweden
[4] Lund Univ, Div Endocrinol, Malmo, Sweden
[5] Skane Univ Hosp, Dept Oncol, Lund, Sweden
基金
瑞典研究理事会;
关键词
Androgen receptor; Breast cancer; Risk factors; Reproductive factors; Oral contraceptives; REPRODUCTIVE FACTORS; ER-ALPHA; EXPRESSION; GROWTH; ENDOCRINE; THERAPY; WOMEN; TESTOSTERONE; PROGESTINS; HISTOLOGY;
D O I
10.1007/s10552-014-0394-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Risk factors for breast cancer vary according to breast cancer subtype. This study analyzes the impact of potential risk factors in breast cancer by androgen receptor (AR) status. A total of 17,035 women were followed in the population-based prospective Malmo Diet and Cancer Study. Baseline data included lifestyle factors including anthropometry, reproductive history, and exogenous hormone use. During follow-up (mean: 12.8 years), 747 invasive breast cancers were diagnosed. Expression of AR was determined by immunohistochemistry in tumor tissue microarrays. AR status was assessable in 516 of 747 tumors (69%). Among these, 467 tumors (90.5%) were AR positive (AR(+)) and 49 tumors (9.5%) were AR negative (AR(-)). AR negativity was significantly associated with estrogen receptor (ER) and progesterone receptor negativity, higher grade and proliferation (Ki67). Cox regression analyses stratified by AR status showed significant associations between reproductive factors and AR(-) breast cancer. The older the woman at first childbirth the higher the risk of AR(-) breast cancer; adjusted HRa parts per thousand currency sign20yrs = 0.35, HR > 20-a parts per thousand currency sign25yrs = 0.62, HRnulliparous = 1.00, HR > 25-a parts per thousand currency sign30yrs = 1.29, HR > 30yrs = 1.92, p (trend) = 0.001. No such association was seen for AR(+) tumors. Similarly, ever oral contraceptive use increased the risk of AR(-) breast cancer [Adj. HR = 2.59, 95% CI (1.26-5.34)] compared to never use, but not for AR(+) breast cancer. Advanced age at first child birth and use of oral contraceptives were associated with increased risk of AR(-) breast cancer. This study may contribute to enhanced understanding of the role of the AR in breast carcinogenesis and improve risk stratification tools for personalized breast cancer prevention.
引用
收藏
页码:945 / 957
页数:13
相关论文
共 50 条
[1]   Tamoxifen-stimulated growth of breast cancer due to p21 loss [J].
Abukhdeir, Abde M. ;
Vitolol, Michele I. ;
Argani, Pedram ;
De Marzo, Angelo M. ;
Karakas, Bedri ;
Konishi, Hiroyuki ;
Gustin, John P. ;
Lauring, Josh ;
Garay, Joseph P. ;
Pendleton, Courtney ;
Konishi, Yuko ;
Blair, Brian G. ;
Brenner, Keith ;
Garrett-Mayer, Elizabeth ;
Carraway, Hetty ;
Bachman, Kurtis E. ;
Park, Ben Ho .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (01) :288-293
[2]  
Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558
[3]  
[Anonymous], 1982, ANN PATHOL, P91
[4]  
[Anonymous], 2000, WHO TECHN REP SER, V894, pi, DOI DOI 10.1596/0-1952-1129-4
[5]   Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study [J].
Bao, Ping-Ping ;
Shu, Xiao Ou ;
Gao, Yu-Tang ;
Zheng, Ying ;
Cai, Hui ;
Deming, Sandra L. ;
Ruan, Zhi-Xian ;
Su, Yinghao ;
Gu, Kai ;
Lu, Wei ;
Zheng, Wei .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (06) :661-671
[6]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[7]   DESIGN AND FEASIBILITY [J].
BERGLUND, G ;
ELMSTAHL, S ;
JANZON, L ;
LARSSON, SA .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (01) :45-51
[8]   ENDOGENOUS HORMONES AND BREAST-CANCER RISK [J].
BERNSTEIN, L ;
ROSS, RK .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :48-65
[9]   Role of the androgen receptor in human breast cancer [J].
Birrell, SN ;
Hall, RE ;
Tilley, WD .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (01) :95-103
[10]   Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer [J].
Birrell, Stephen N. ;
Butler, Lisa M. ;
Harris, Jonathan M. ;
Buchanan, Grant ;
Tilley, Wayne D. .
FASEB JOURNAL, 2007, 21 (10) :2285-2293